 ceftazidim treatment cystic fibrosi resist organ sputum faec ceftazidim intraven agent respiratori tract infect patient cystic fibrosi risk beta lactamas antibiot resist high monotherapi emerg resist bacteria sputum patient mean age patient year equal number male femal patient pseudomona aeruginosa ceftazidim resist bacterium respiratori tract colonis patient ceftazidim resist aeruginosa isol colonis patient ceftazidim resist organ faec patient eighti cent resist faecal organ singl isol resist organ faec success sampl patient case ceftazidim resist enter isol sputum patient aeruginosa ceftazidim resist enter organ non-colonis patient use ceftazidim singl intraven agent exacerb cystic fibrosi reservoir ceftazidim resist bacteria